Related Experiment Video
Updated: Sep 9, 2025
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Salivary Pepsin Measurement in Laryngopharyngeal Reflux Disease: A Systematic Review of Diagnostic Accuracy and
Apolline Hiernaux1, Anne Trelcat2, Jérôme R Lechien3
1Department of Surgery, Research Institute for Language Science and Technology, University of Mons (UMons), Mons, Belgium; Faculty of Medicine and Biomedical Science, University of Namur, Namur, Belgium; Department of Otolaryngology, Elsan Hospital, Paris, France.
Objective:
To analyze the methods used for digestive enzyme measurements in saliva of patients with laryngopharyngeal reflux disease (LPRD) and to investigate their respective diagnostic performances.
Methods:
Three independent investigators conducted a PubMED, Scopus, and Cochrane Library database search for studies investigating the digestive saliva enzyme measurements in LPRD patients according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements.
Results:
Of the 183 screened studies, 38 studies met the inclusion criteria (1461 females (47.5%) and 1614 males (52.5%)). The mean age of patients was 43.5 years. Two studies assessed the accuracy of salivary pepsin in pediatric populations. Twelve studies included patients with an objective LPRD diagnosis at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing. The lateral flow immunohistochemistry (Peptest) and ELISA were the most common approaches for measuring pepsin. Sensitivity ranged widely (27.0-93.8%) across different methods and thresholds, with Peptest showing 27.0-87.1% sensitivity and 25.0-100% specificity at ≥16 ng/mL threshold. ELISA demonstrated 20.0-93.8% sensitivity and 45.5-84.3% specificity across various cutoff values. Higher thresholds generally improved specificity at the expense of sensitivity. Multiple saliva measurements throughout the 24-hour testing period improved the sensitivity and specificity of the pepsin test. Only three studies considered the measurement of other digestive enzymes, primarily bile salts, as biomarkers of LPRD.
Conclusion:
The methods of salivary pepsin collection and measurement substantially influence its diagnostic performance. Future comparative studies are needed to determine the most accurate methodological approach and to establish consensus guidelines for salivary pepsin and other digestive enzyme measurements in LPRD diagnosis through standardized collection, storage, and measurement protocols.
More Related Videos
10:18Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...